Hyderabad: Cancer research is currently undergoing a massive paradigm shift. Once thought to be triggered by a single genetic error, cancer is now understood as a complex and multi-layered ...

CCNSB researchers at IIIT Hyderabad focus on genomics, epigenetics and AI for cancer detection and treatment: Our Bureau, Bengaluru Monday, February 16, 2026, 15:50 Hrs [IST] Rese ...

Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced the appointment of Elena Helman, PhD, as Vice President of Oncology Solutions. In this ...

WEST LAFAYETTE, Ind. — With recent advances, cancer research now generates vast amounts of information. The data could help researchers detect patterns in cancer cells and stop their growth, but the ...

A team of the University of Barcelona and the Biomedical Research Institute of Barcelona (IRB Barcelona) has designed a new bioinformatics tool to identify the chromosomal alterations that are ...

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and ...

Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable disease, defined as a malignancy of the epithelial ducts in breast tissue.

The biomarker, G-protein-coupled receptor 176 (GPR176), may be a driver in the progression of ovarian cancer and potential target for gene therapy, suggested researchers of a new study. Building on ...

How neutrophils are reprogrammed by cancer cells could serve as a predictor of cancer evolution, with the cytokine CCL3 ...